Literature DB >> 28268009

Why we need more septal myectomy surgeons: An emerging recognition.

Barry J Maron1, Joseph A Dearani2, Martin S Maron3, Steve R Ommen2, Hassan Rastegar3, Rick A Nishimura2, Daniel G Swistel4, Mark V Sherrid4, Anthony Ralph-Edwards5, Harry Rakowski5, Nicholas G Smedira6, Ethan J Rowin3, Milind Y Desai6, Harry M Lever6, Paolo Spirito7, Paolo Ferrazzi7, Hartzell V Schaff2.   

Abstract

Mesh：

Year:  2017        PMID： 28268009     DOI： 10.1016/j.jtcvs.2016.12.038

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  10 in total

Review 1.  Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Joon Hwa Hong; Anita Nguyen; Hartzell Vernon Schaff
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-07

2.  Alcohol septal ablation: in which patients and why?

Authors:  Paolo Spirito; Jessica Rossi; Barry J Maron
Journal:  Ann Cardiothorac Surg       Date:  2017-07

3.  Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience.

Authors:  Hassan Rastegar; Griffin Boll; Ethan J Rowin; Noreen Dolan; Catherine Carroll; James E Udelson; Wendy Wang; Philip Carpino; Barry J Maron; Martin S Maron; Frederick Y Chen
Journal:  Ann Cardiothorac Surg       Date:  2017-07

4.  Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.

Authors:  Zahara Meghji; Anita Nguyen; Benish Fatima; Jeffrey B Geske; Rick A Nishimura; Steve R Ommen; Brian D Lahr; Joseph A Dearani; Hartzell V Schaff
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

5.  Transaortic Shallow Septal Myectomy and Cutting of Secondary Fibrotic Mitral Valve Chordae-A 5-Year Single-Center Experience in the Treatment of Hypertrophic Obstructive Cardiomyopathy.

Authors:  Lucian Florin Dorobantu; Toma Andrei Iosifescu; Razvan Ticulescu; Maria Greavu; Maria Alexandrescu; Andrei Dermengiu; Miruna Mihaela Micheu; Monica Trofin
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

Review 6.  Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.

Authors:  Daniel J Philipson; Eugene C DePasquale; Eric H Yang; Arnold S Baas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

7.  Image-Based Simulative Training for Myectomy in Hypertrophic Cardiomyopathy: An Emerging Necessity.

Authors:  V Rao Parachuri; Srilakshmi M Adhyapak
Journal:  Indian Heart J       Date:  2019-04-16

8.  Thoracoscopic Trans-mitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in the Elderly.

Authors:  Peijian Wei; Jian Liu; Jiexu Ma; Yanjun Liu; Tong Tan; Hongxiang Wu; Wei Zhu; Zhao Chen; Jimei Chen; Jian Zhuang; Huiming Guo
Journal:  Front Cardiovasc Med       Date:  2022-03-09

9.  Routine histopathology of septal myectomy for hypertrophic obstructive cardiomyopathy in a greek cohort.

Authors:  Nikolaos S Ioakeimidis; Antonios Pitsis; Dimitrios Ntelios; Thomas Zegkos; Timotheos Kelpis; Theodora Papamitsou; Despoina Parcharidou; Georgios Efthimiadis; Soultana Meditskou
Journal:  Histol Histopathol       Date:  2021-07-30       Impact factor: 2.303

10.  Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography.

Authors:  Giovanni La Canna; Iside Scarfò; Irina Arendar; Antonio Colombo; Lucia Torracca; Davide Margonato; Matteo Montorfano; Ottavio Alfieri
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.